Abstract
AbstractOdontogenic tumors are rare lesions with unknown etiopathogenesis. Most of them are benign, but local aggressiveness, infiltrative potential, and high recurrence rate characterize some entities. The MAP-kinase pathway activation can represent a primary critical event in odontogenic tumorigenesis. Especially, the BRAF V600E mutation has been involved in 80–90% of ameloblastic lesions, offering a biological rationale for developing new targeted therapies. The study aims to evaluate the BRAF V600E mutation in odontogenic lesions, comparing three different detection methods and focusing on the Sequenom MassARRAY System. 81 surgical samples of odontogenic lesions were subjected to immunohistochemical analysis, Sanger Sequencing, and Matrix-Assisted Laser Desorption/Ionization-Time of Flight mass spectrometry (Sequenom). The BRAF V600E mutation was revealed only in ameloblastoma samples. Moreover, the presence of BRAF V600E was significantly associated with the mandibular site (ρ = 0.627; P value <0.001) and the unicystic histotype (ρ = 0.299, P value <0.001). However, any significant difference of 10-years disease-free survival time was not revealed. Finally, Sequenom showed to be a 100% sensitive and 98.1% specific, suggesting its high-performance diagnostic accuracy. These results suggest the MAP-kinase pathway could contribute to ameloblastic tumorigenesis. Moreover, they could indicate the anatomical specificity of the driving mutations of mandibular ameloblastomas, providing a biological rational for developing new targeted therapies. Finally, the high diagnostic accuracy of Sequenom was confirmed.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Mascitti, M. et al. Odontogenic tumours: a 25-year epidemiological study in the Marche region of Italy. Eur. Arch. Otorhinolaryngol. 277, 527–538 (2020).
2. Barnes, L., UniversitèatsSpital Zèurich. Departement Pathologie., International Academy of Pathology., World Health Organization. & International Agency for Research on Cancer. Pathology and Genetics of Head and Neck Tumours (IARC Press, 2005).
3. Rubini, C. et al. Odontogenic tumors: a retrospective clinicopathological study from two Italian centers. Pathologica 109, 35–46 (2017).
4. El-Naggar, A. K. et al. WHO classification of Head and Neck Tumours (International Agency for Research on Cancer, 2017).
5. Hayward, J. R. Recurrent ameloblastoma 30 years after surgical treatment. J. Oral. Surg. 31, 368–370 (1973).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献